Healthcare
AC Future – SUCCESS PAGE – August 21, 2025
AC Future is reimagining the way people live, travel, and work with the world’s smartest mobile living platform.
AC Future is reimagining the way people live, travel, and work with the world’s smartest mobile living platform.
AC Future is reimagining the way people live, travel, and work with the world’s smartest mobile living platform.
Novel Bio is replacing 50-year-old technology with their NBx Platform. It improves speed, yield, cost, and quality in DNA manufacturing.
Novel Bio is replacing 50-year-old technology with their NBx Platform. It improves speed, yield, cost, and quality in DNA manufacturing.
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market
Regenxbio [NASDAQ: RGNX] has three assets in pivotal trials with the potential to become standard of care in markets worth a total of $26B.
BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market
Aurenar has developed a non-invasive device that boosts the body’s natural control of inflammation, improving ICU outcomes and lowering costs.
Aurenar has developed a non-invasive device that boosts the body’s natural control of inflammation, improving ICU outcomes and lowering costs.
A biopharmaceutical company developing the first hormone-free, topical treatment for Vulvovaginal Atrophy (VVA)